Cargando…

Association between the cardiometabolic index and non-alcoholic fatty liver disease: insights from a general population

BACKGROUND: Emerging evidence suggests that cardiometabolic index (CMI) is closely related to diabetes, hypertension, stroke, cardiovascular disease, and kidney disease, which implies that CMI has the value as an indicator of metabolic diseases. However, data on the relationships between CMI and non...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Jiawang, Xiong, Hailan, Zhang, Huimin, Hu, Chong, Lu, Song, Zou, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756663/ https://www.ncbi.nlm.nih.gov/pubmed/35021995 http://dx.doi.org/10.1186/s12876-022-02099-y

Ejemplares similares

Abdominal obesity phenotypes are associated with the risk of developing non-alcoholic fatty liver disease: insights from the general population
por: Kuang, Maobin, et al.
Publicado: (2022)

Association between hypertriglyceridemic-waist phenotype and non-alcoholic fatty liver disease: a general population-based study
por: Yang, Ming, et al.
Publicado: (2022)

Sex-Specific Contribution of Cardiometabolic Index in Predicting Metabolic Dysfunction-Associated Fatty Liver Disease: Insights from a General Population
por: Gu, Dongxing, et al.
Publicado: (2023)

The value of combining the simple anthropometric obesity parameters, Body Mass Index (BMI) and a Body Shape Index (ABSI), to assess the risk of non-alcoholic fatty liver disease
por: Kuang, Maobin, et al.
Publicado: (2022)

The triglyceride glucose-body mass index: a non-invasive index that identifies non-alcoholic fatty liver disease in the general Japanese population
por: Hu, Haofei, et al.
Publicado: (2022)

Waist-to-height ratio and non-alcoholic fatty liver disease in adults
por: Sheng, Guotai, et al.
Publicado: (2021)

Non-Alcoholic Fatty Liver Disease: The Emerging Burden in Cardiometabolic and Renal Diseases
por: Han, Eugene, et al.
Publicado: (2017)

Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease
por: Klisic, Aleksandra, et al.
Publicado: (2021)

Sex and age differences in the association of fatty liver index-defined non-alcoholic fatty liver disease with cardiometabolic risk factors: a cross-sectional study
por: Fresneda, Sergio, et al.
Publicado: (2022)

Association of remnant cholesterol with nonalcoholic fatty liver disease: a general population-based study
por: Zou, Yang, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease is associated with increased risk of chronic kidney disease
por: Cai, Xiaoyan, et al.
Publicado: (2021)

Association between the alanine aminotransferase/aspartate aminotransferase ratio and new-onset non-alcoholic fatty liver disease in a nonobese Chinese population: a population-based longitudinal study
por: Zou, Yang, et al.
Publicado: (2020)

Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
por: Castellana, Marco, et al.
Publicado: (2021)

Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals
por: Della Pepa, Giuseppe, et al.
Publicado: (2017)

The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: A longitudinal study
por: Aneni, Ehimen C., et al.
Publicado: (2020)

Lipid metabolism, BMI and the risk of nonalcoholic fatty liver disease in the general population: evidence from a mediation analysis
por: Lu, Song, et al.
Publicado: (2023)

Prevalence and predictors of non-alcoholic fatty liver disease as defined by the fatty liver index in a type 2 diabetes population
por: SILAGHI, CRISTINA ALINA, et al.
Publicado: (2016)

Non-Alcoholic Fatty Liver Disease and Its Association with Depression in Korean General Population
por: Jung, Ju Young, et al.
Publicado: (2019)

Remnant cholesterol/high-density lipoprotein cholesterol ratio is a new powerful tool for identifying non-alcoholic fatty liver disease
por: Zou, Yang, et al.
Publicado: (2022)

Utility of traditional and non-traditional lipid indicators in the diagnosis of nonalcoholic fatty liver disease in a Japanese population
por: Lu, Song, et al.
Publicado: (2022)

The albumin-to-alkaline phosphatase ratio as an independent predictor of future non-alcoholic fatty liver disease in a 5-year longitudinal cohort study of a non-obese Chinese population
por: Sheng, Guotai, et al.
Publicado: (2021)

Fatty Liver Index is a valid predictor of non-alcoholic fatty liver disease (NAFLD) in pregnancy
por: Koralegedara, Iresha Sandamali, et al.
Publicado: (2022)

Fatty Liver Index (FLI) Identifies Not Only Individuals with Liver Steatosis but Also at High Cardiometabolic Risk
por: Carli, Fabrizia, et al.
Publicado: (2023)

The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus
por: Li, Mengnan, et al.
Publicado: (2021)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease Defined by Fatty Liver Index and Incidence of Heart Failure in the Korean Population: A Nationwide Cohort Study
por: Han, Byoungduck, et al.
Publicado: (2022)

Relationship Between Gallstone Disease and Cardiometabolic Risk Factors in Elderly People with Non-Alcoholic Fatty Liver Disease
por: Hung, Man-Chen, et al.
Publicado: (2020)

Effectiveness of phosphatidylcholine in alleviating steatosis in patients with non-alcoholic fatty liver disease and cardiometabolic comorbidities (MANPOWER study)
por: Maev, Igor V, et al.
Publicado: (2020)

Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease
por: Naseri, Kaveh, et al.
Publicado: (2022)

Predictivity of fatty liver index for non-alcoholic fatty liver disease in lean females with polycystic ovary syndrome
por: Arıkan, Didem, et al.
Publicado: (2022)

The Role of the Fatty Liver Index (FLI) in the Management of Non-Alcoholic Fatty Liver Disease: A Systematic Review
por: Biciusca, Teodora, et al.
Publicado: (2023)

Role of fatty liver index in risk-stratifying comorbid disease outcomes in non-alcoholic fatty liver disease
por: Ho, Brian, et al.
Publicado: (2023)

Cardiometabolic index: A new predictor for metabolic associated fatty liver disease in Chinese adults
por: Duan, Shaojie, et al.
Publicado: (2022)

Usefulness of the triglyceride glucose-body mass index in evaluating nonalcoholic fatty liver disease: insights from a general population
por: Wang, Rongsheng, et al.
Publicado: (2021)

Multiparametric MR Index for the Diagnosis of Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease
por: Kim, Jeong Woo, et al.
Publicado: (2020)

Association between non-alcoholic fatty liver disease and subclinical left ventricular dysfunction in the general population
por: Hirose, Kazutoshi, et al.
Publicado: (2023)

The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease
por: Sheng, Guotai, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiometabolic Risk Factors in Adolescence: A Cross-Sectional Study of 1874 General Population Adolescents
por: Lawlor, Debbie A., et al.
Publicado: (2014)

Myo-inositol supplementation improves cardiometabolic factors, anthropometric measures, and liver function in obese patients with non-alcoholic fatty liver disease
por: Arefhosseini, Sara, et al.
Publicado: (2023)

Association between hemoglobin glycation index and non-alcoholic fatty liver disease
por: Xing, Yuling, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_n7foe1ubjm87mlcldm0ufp5d7t